La vendita allo scoperto per Rogers dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Rogers. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Rogers (NYSE:ROG) Azioni, Report sulle vendite allo scoperto

Rogers

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: advanced connectivity solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and power electronics solutions, which sells ceramic substrate materials for power module applications. The firm generates revenue in the United States, China, and Germany, but has a presence around the world.

Rogers Corp

ROGUE ONE INC. by Rogue One Inc

Rogers Communications Inc

ROGERS COMMUN INC A by Rogers Communications, Inc.

Rogers Sugar Inc

Rogue Baron PLC Ordinary Shares

Rogue One Inc

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.85 by 15.29 percent. The company reported quarterly sales of $210.300 million which missed the analyst consensus estimate of $220.100 million by 4.45 percent. This is a 8.23 percent decrease over sales of $229.148 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

Rogers Q3 2024 Adj. EPS $0.98 Beats $0.85 Estimate, Sales $210.300M Miss $220.100M Estimate

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) is looking for Q4 GAAP EPS of $(0.15)-0.15..

Guidance

Rogers Sees Q4 GAAP EPS $(0.15)-0.15.

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) is looking for Q4 Adj EPS of $0.30-0.60 vs $0.83 analyst estimate. sees sales of $185.000 million-200.000 million vs $211.75 million estimate.

Rogers Sees Q4 Adj EPS $0.30-0.60 vs $0.83 Est; Sees Sales $185.000M-200.000M vs $211.75M Est.

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) is preparing to release its quarterly earnings on Thursday, 2024-10-24. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Rogers to report an earnings per share (EPS) of $0.85.
Anticipation surrounds Rogers's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
The company's EPS beat by $0.09 in the last quarter, leading to a 0.38% increase in the share price on the following day.
Here's a look at Rogers's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.60</td>
<td>0.55</td>
<td>1</td>
<td>1.13</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.69</td>
<td>0.58</td>
<td>0.6</td>
<td>1.24</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>10.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729706535_0.png" alt="eps graph" />
<h3>Tracking Rogers's Stock Performance</h3>
Shares of Rogers were trading at $100.63 as of October 22. Over the last 52-week period, shares are down 15.97%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ROG/earnings">To track all earnings releases for Rogers visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Rogers's Earnings

Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (ARCA:DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
<h2>What Are Smart Beta ETFs?</h2>
Products that are based on market cap weighted indexes, which are strategies designed to reflect a specific market segment or the market as a whole, have traditionally dominated the ETF industry.
Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.
On the other hand, some investors who believe that it is possible to beat the market by superior stock selection opt to invest in another class of funds that track non-cap weighted strategies--popularly known as smart beta.
This kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, or a mix of such characteristics.
Methodologies like equal-weighting, one of the simplest options out there, fundamental weighting, and volatility/momentum based weighting are all choices offered to investors in this space, but not all of them can deliver superior returns.
<h2>Fund Sponsor &amp; Index</h2>
The fund is sponsored by Wisdomtree. It has amassed assets over $625.40 million, making it one of the larger ETFs in the World ETFs. DNL seeks to match the performance of the WisdomTree Global ex-U.S. Quality Dividend Growth Index before fees and expenses.
The WisdomTree Global ex-U.S. Quality Dividend Growth Index is a fundamentally weighted index that measures the performance of dividend paying stocks with growth characteristics in the developed and emerging markets outside of the United States.
<h2>Cost &amp; Other Expenses</h2>
For ETF investors, expense ratios are an important factor when considering a fund&#39;s return; in the long-term, cheaper funds actually have the ability to outperform their more expensive cousins if all other things remain the same.
Annual operating expenses for this ETF are 0.42%, making it one of the cheaper products in the space.
It has a 12-month trailing dividend yield of 1.72%.
<h2>Sector Exposure and Top Holdings</h2>
It is important to delve into an ETF&#39;s holdings before investing despite the many upsides to these kinds of funds like diversified exposure, which minimizes single stock risk. And, most ETFs are very transparent products that disclose their holdings on a daily basis.
Looking at individual holdings, Taiwan Semiconductor Manufacturing Co Ltd&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tsm#NYSE">TSM</a>) accounts for about 6.47% of total assets, followed by Novo Nordisk A/s-B (OTC: <a class="ticker" href="https://www.benzinga.com/stock/nonof#OTC">NONOF</a>) and Roche Holding Ag (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rog#NYSE">ROG</a>).
<h2>Performance and Risk</h2>
The ETF has added about 6.31% so far this year and was up about 13.30% in the last one year (as of 09/17/2024). In the past 52-week period, it has traded between $31.84 and $40.81.
DNL has a beta of 0.96 and standard deviation of 18.66% for the trailing three-year period, which makes the fund a medium risk choice in the space. With about 325 holdings, it effectively diversifies company-specific risk.
<h2>Alternatives</h2>
WisdomTree Global ex-U.S. Quality Dividend Growth ETF is a reasonable option for investors seeking to outperform the World ETFs segment of the market. However, there are other ETFs in the space which investors could consider.
IShares Core Dividend Growth ETF (ARCA:DGRO) tracks Morningstar US Dividend Growth Index and the Vanguard Dividend Appreciation ETF (ARCA:VIG) tracks NASDAQ US Dividend Achievers Select Index. IShares Core Dividend Growth ETF has $29.95 billion in assets, Vanguard Dividend Appreciation ETF has $85.25 billion. DGRO has an expense ratio of 0.08% and VIG charges 0.06%.
Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the World ETFs.
<a href="https://www.zacks.com/stock/news/2336919/is-wisdomtree-global-ex-u-s-quality-dividend-growth-etf-dnl-a-strong-etf-right-now?cid=CS-BENZ-FT-smart_beta_etf-2336919">To read this article on Zacks.com click here.</a>

Large Cap

Sector ETFs

Dividends

Small Cap

Markets

Trading Ideas

ETFs

DGRO

NONOF

Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF a Strong ETF Right Now?

Management

MKSI

MKS Instruments Appoints Ram Mayampurath As Executive Vice President, Chief Financial Officer, And Treasurer, Effective October 14, 2024; Joins From Rogers Corporation With Over 25 Years Of Financial Leadership Experience

Rogers CFO  Ram Mayampurath Resigned; Laura Russell To Assume Role As Interim CFO

Rogers Corporation Expects Q3 Net Sales Of $215M - $225M (Est $226.65M), Adj EPS Of $0.75 - $0.95 (Est $0.94)

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.60 by 15 percent. The company reported quarterly sales of $214.200 million which missed the analyst consensus estimate of $216.150 million by 0.90 percent. This is a 7.20 percent decrease over sales of $230.821 million the same period last year.

Rogers Q2 2024 Adj EPS $0.69 Beats $0.60 Estimate, Sales $214.200M Miss $216.150M Estimate

Rogers will continue to support its advanced circuit materials customers through its existing footprint in China and the U.S.
These actions are expected to improve operating profit between&nbsp;$7&nbsp;to&nbsp;$9 million&nbsp;annually, once fully implemented. To achieve these savings the Company expects to incur total charges in the range of&nbsp;$18&nbsp;to&nbsp;$28 million, comprised of employee severance and related shutdown expenses.
&nbsp;

Rogers Plans To Streamline Operations; Intends To Wind Down Manufacturing Of Advanced Circuit Materials And Other Related Activities At Its Evergem, Belgium Factory By Mid-2025

Shares of Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/AON/earnings">quarterly financial results</a>.
Aon posted adjusted earnings of $5.66 per share, missing market estimates of $5.91 per share. The company's sales came in at $4.070 billion versus expectations of $4.126 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Aon shares dipped 7.4% to $283.19 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) shares jumped 73.3% to $1.2475 after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) gained 63% to $0.0845.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares gained 55% to $2.01 after dipping 16% on Thursday.</li>
<li>Universal Logistics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULH#NASDAQ">ULH</a>) surged 45.2% to $47.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Focus Universal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) jumped 40% to $0.3967 after the company announced board approval for the spin-off of Lusher.</li>
<li>BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) gained 37% to $2.68.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) gained 29% to $0.6502. Concord Medical filed 2023 annual report on Form 20-F.</li>
<li>Exponent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPO#NASDAQ">EXPO</a>) shares climbed 28.5% to $102.41 after the company reported better-than-expected first-quarter financial results.</li>
<li>Skillsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKIL#NYSE">SKIL</a>) climbed 26.4% to $8.60.</li>
<li>MultiMetaVerse Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMV#NASDAQ">MMV</a>) gained 24.2% to $0.61.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) gained 23% to $14.02 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company reported a year-over-year increase in quarterly daily active users.</li>
<li>Tutor Perini Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) surged 22.2% to $16.98 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) surged 22.2% to $0.9888.</li>
<li>U.S. Silica Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLCA#NYSE">SLCA</a>) gained 20% to $15.67 after the company reported first-quarter financial results and entered into a definitive agreement to be acquired by funds managed by affiliates of Apollo.</li>
<li>Earlyworks Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) rose 19.7% to $0.8725 after gaining 19% on Thursday.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) surged 19.5% to $23.03.</li>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares gained 19.3% to $1.0150 after falling over 43% on Thursday.</li>
<li>ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) surged 18.9% to $1.9150. ATRenew announced appointment of new director.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) gained 17.5% to $13.39.</li>
<li>Freight Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) climbed 17% to $1.0702 after gaining 5% on Thursday.</li>
<li>Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) shares gained 16% to $68.20 after the company reported better-than-expected first-quarter FY24 earnings.</li>
<li>AppFolio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) surged 16% to $251.22 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance above estimates.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) gained 15% to $7.97 after the company reported better than expected first-quarter earnings and issued guidance.</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) shares rose 13.7% to $208.63 after the company reported better-than-expected third-quarter financial results.</li>
<li>Rogers Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) surged 12.7% to $123.46 after the company beat first-quarter EPS and sales estimates.</li>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) gained 11.3% to $7.92</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) rose 10.6% to $172.52 the company posted upbeat results for its first quarter. Alphabet's board authorized an additional share repurchase program of up to $70 billion and also announced its first-ever quarterly dividend.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) gained 8.8% to $18.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $20 to $27.</li>
<li>AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) climbed 8.6% to $174.20 following second-quarter results.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) shares gained 8.4% to $0.8725 after gaining 15% on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) shares fell 48.8% to $1.31 after the company announced the termination of its merger agreement.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) fell 46.7% to $0.1540 after the company reported pricing of $2.7 million public offering.</li>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 27.7% to $0.1584.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) dipped 25.3% to $0.5752.</li>
<li>Nature Wood Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWGL#NASDAQ">NWGL</a>) fell 24.5% to $12.71.</li>
<li>IMAC Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BACK#NASDAQ">BACK</a>) dipped 22.9% to $3.93.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) fell 20.8% to $1.10.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) fell 19.3% to $4.84.</li>
<li>Saia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) dipped 19.1% to $439.40 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Kinsale Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) fell 17.3% to $374.29 following first-quarter results.</li>
<li>Aclarion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) fell 15.5% to $0.3319. Aclarion shares jumped 36% on Thursday after the company announced that its Nociscan solution will be used in the upcoming LIFEHAB trial evaluating the diagnosis and treatment of chronic low back pain.</li>
<li>Oil States International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OIS#NYSE">OIS</a>) fell 15% to $4.5250 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Boyd Gaming Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) shares declined 14.8% to $53.55 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXI#NASDAQ">ATXI</a>) fell 13.5% to $7.59.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) fell 12.7% to $0.2260 after dipping 39% on Thursday. Chicken Soup For The Soul Entertainment received delinquency letter from the Nasdaq.</li>
<li>TriNet Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) fell 11.5% to $112.11 after the company reported worse-than-expected first-quarter results and issued weak guidance.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares fell 11.1% to $31.23 after the company reported worse-than-expected first-quarter sales results and issued EPS guidance below estimates.</li>
<li>Accolade, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) dipped 10.6% to $8.22 following quarterly results.</li>
<li>XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) fell 10.2% to $106.14.</li>
<li>Atlassian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) shares fell 9.4% to $179.76 after the company reported third-quarter financial results. Atlassian said Scott Farquhar has decided to step down from his role as co-CEO, effective Aug. 31. Cannon-Brookes will continue to lead Atlassian as CEO.</li>
<li>Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) shares fell 8.8% to $0.8180 after the company announced pricing of underwritten public offering of common stock and warrants.</li>
<li>SCWorx Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) fell 8.7% to $2.52 after surging 36% on Thursday.   </li>
<li>ACM Research, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) fell 8.3% to $25.94 after announcing preliminary unaudited revenue and shipments for the first quarter.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) shares fell 8.2% to $57.63 after the company reported first-quarter financial results.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) fell 7.8% to $2.52. Processa Pharmaceuticals shares jumped 50% on Thursday after HC Wainwright &amp; Co initiated coverage on the stock with a Buy rating and announced an $8 price target.</li>
<li>Red Rock Resorts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) dipped 7.4% to $54.83.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) declined 7.3% to $128.07.</li>
<li>Allison Transmission Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) fell 6.6% to $74.97 following first-quarter results.</li>
<li>Old Dominion Freight Line, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) fell 6.2% to $184.41.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 6.3% to $129.17 after the company reported first-quarter financial results.</li>
<li>Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) fell 4% to $116.44 following weak earnings.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38459594/how-to-earn-500-a-month-from-dominos-pizza-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Domino&#8217;s Pizza Stock Ahead Of Q1 Earnings</a>

Intraday Update

Movers

ACCD

ACMR

ACON

AILE

AIRE

ALSN

APPF

ARCB

ATXI

BACK

BDRX

CGEM

CSSE

DXCM

ELWS

EXPO

FCUV

FRGT

GOOG

GOOGL

ICLK

INTC

KNSL

KTOS

Kintara Therapeutics, Inc. - Common Stock

KTRA

Eaton Vance Massachusetts Municipal Income Trust

NIVF

NUWE

NWGL

ODFL

PCSA

PEGY

RERE

ROKU

SAIA

SBFM

SGBX

SKIL

SLCA

SNAP

TEAM

TNET

TVGN

VINC

WORX

ZVSA

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

U.S. stocks were higher, with the Dow Jones jumping over 150 points on Friday.
Shares of Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/24/04/38460429/why-are-skechers-shares-soaring-today">first-quarter FY24 earnings</a>.
Skechers reported first-quarter FY24 sales growth of 12.5% year-on-year to $2.251 billion, beating the analyst consensus estimate of $2.204 billion. EPS of $1.33 beat the analyst consensus of $1.10, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Skechers raised FY24 sales outlook from $8.60 billion-$8.80 billion to $8.725 billion-$8.875 billion, against an estimate of $8.781 billion. The company also raised FY24 EPS outlook from $3.65-$3.85 to $3.95-4.10 versus an estimate of $3.90.
Skechers U.S.A. shares climbed 16% to $68.20 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Universal Logistics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULH#NASDAQ">ULH</a>) shares jumped 45.2% to $47.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Exponent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPO#NASDAQ">EXPO</a>) shares gained 28.5% to $102.41 after the company reported better-than-expected first-quarter financial results.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) rose 23% to $14.02 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company reported a year-over-year increase in quarterly daily active users.</li>
<li>Tutor Perini Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) climbed 22.2% to $16.98 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance.</li>
<li>U.S. Silica Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLCA#NYSE">SLCA</a>) rose 20% to $15.67 after the company reported first-quarter financial results and entered into a definitive agreement to be acquired by funds managed by affiliates of Apollo.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) shares jumped 19.5% to $23.03.</li>
<li>ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) gained 18.9% to $1.9150. ATRenew announced appointment of new director.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) rose 17.5% to $13.39.</li>
<li>AppFolio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) gained 16% to $251.22 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance above estimates.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) rose 15% to $7.97 after the company reported better than expected first-quarter earnings and issued guidance.</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) shares gained 13.7% to $208.63 after the company reported better-than-expected third-quarter financial results.</li>
<li>Rogers Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) rose 12.7% to $123.46 after the company beat first-quarter EPS and sales estimates.</li>
<li>Canopy Growth Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) gained 12.5% to $9.78.</li>
<li>Sonic Automotive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>) surged 12.2% to $63.60. B of A Securities analyst John Murphy upgraded Sonic Automotive from Underperform to Buy and raised the price target from $55 to $68.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) gained 10.6% to $172.52 the company posted upbeat results for its first quarter. Alphabet's board authorized an additional share repurchase program of up to $70 billion and also announced its first-ever quarterly dividend.</li>
<li>KB Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KB#NYSE">KB</a>) gained 10% to $55.17 following quarterly results.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) climbed 9.9% to $8.22.</li>
<li>Redfin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) gained 9.8% to $5.69.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) rose 9.2% to $7.73.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) rose 8.8% to $18.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $20 to $27.</li>
<li>AutoNation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) gained 8.6% to $174.20 following second-quarter results.</li>
<li>Minerals Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) gained 7.9% to $76.73 following upbeat earnings.</li>
<li>SkyWest, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYW#NASDAQ">SKYW</a>) surged 7.4% to $78.55 after the company reported better-than-expected quarterly financial results.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) rose 6.6% to $3.7950. Geron is expected to release its first quarter 2024 financial results on Thursday, May 2.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) surged 6.6% to $839.70.</li>
<li>Carlisle Companies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>) rose 5.5% to $403.08 after the company reported better-than-expected quarterly financial results.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) gained 5.1% to $1.45.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38456583/around-1m-bet-on-biohaven-check-out-these-4-stocks-insiders-are-buying">Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying</a>

GERN

OUST

PACB

RDFN

SKYW

SMCI

XPEV

Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday

WIIM

Rogers shares are trading higher after the company beat Q1 EPS and sales estimates.

Rogers Sees Q2 Adj. EPS $0.50-$0.70, Net Sales $210M-$220M

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.55 by 5.45 percent. This is a 33.33 percent decrease over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $213.400 million which beat the analyst consensus estimate of $210.000 million by 1.62 percent. This is a 12.49 percent decrease over sales of $243.847 million the same period last year.

Rogers Q1 2024 Adj EPS $0.58 Beats $0.55 Estimate, Sales $213.400M Beat $210.000M Estimate

Shares of Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) fell sharply during Thursday&rsquo;s session after the company reported <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37261895/4-etsy-analysts-stand-firm-on-ratings-post-q4-earnings-point-to-buyer-growth-fee-ex">mixed fourth-quarter financial results.</a>
Etsy reported quarterly earnings of 62 cents per share which missed the analyst consensus estimate of 78 cents. The company reported quarterly sales of $842.3 million, beating the analyst consensus estimate of $827.81 million. 
Etsy shares dipped 7.5% to $71.34 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>La Rosa Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrhc#NASDAQ">LRHC</a>) shares jumped 160.7% to $3.6499 after the company said it has acquired a 100% interest in the Company&#39;s franchisee - La Rosa Realty Winter Garden LLC located in Winter Garden, Florida.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) jumped 91.4% to $0.4150 after the company revealed the sale of Complex Networks to NTWRK, a live-streaming video commerce platform. The deal, valued at $108.6 million, will also result in a 16% reduction in BuzzFeed&rsquo;s workforce.</li>
<li>Monopar Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnpr#NASDAQ">MNPR</a>) rose 80.7% to $1.03 after the company disclosed promising preclinical data for its MNPR-101 radiopharma program targeting advanced cancers.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) shares gained 40.8% to $12.21 after posting better-than-expected fourth-quarter results.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) jumped 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax&#39;s prototype Covid-19 vaccine (NVX-COV2373).</li>
<li>EZFill Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezfl#NASDAQ">EZFL</a>) rose 34.3% to $1.86. EzFill announced preliminary 2023 revenues of $23 million, up 54% year over year.</li>
<li>Mercurity Fintech Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mfh#NASDAQ">MFH</a>) jumped 30% to $2.93.</li>
<li>Mativ Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matv#NYSE">MATV</a>) gained 27.6% to $15.00 following upbeat earnings.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) shares climbed 26.9% to $1.6242 after the company received CE Mark from DEKRA Certification B.V. to market Venus Versa Pro in Europe.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 26% to $4.0680 following upbeat results.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) rose 22.2% to $9.19 after announcing a $325.0 million private placement.</li>
<li>Remitly Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rely#NASDAQ">RELY</a>) shares rose 19.5% to $21.13 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) gained 19.3% to $18.13. B. Riley&rsquo;s board issued a statement regarding internal review.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) jumped 19.2% to $875.07. Supermicro announced a proposed offering of $1.5 billion of convertible senior notes due 2029.</li>
<li>Bone Biologics Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bblg#NASDAQ">BBLG</a>) gained 18.4% to $3.73.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) rose 17.5% to $18.00 following strong sales results.</li>
<li>ACV Auctions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acva#NASDAQ">ACVA</a>) gained 16.9% to $16.37 after the company reported better-than-expected fourth-quarter financial results and announced the settlement of its antitrust litigation related to the AutoIMS technology platform.</li>
<li>FTI Consulting, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fcn#NYSE">FCN</a>) jumped 15.5% to $219.72 following upbeat results.</li>
<li>NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) rose 15.4% to $778.61 after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.</li>
<li>OUTFRONT Media Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/out#NYSE">OUT</a>) gained 15.4% to $14.35 following upbeat results.</li>
<li>Lantheus Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lnth#NASDAQ">LNTH</a>) rose 14.4% to $64.90 following strong results.</li>
<li>Enerplus Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/erf#NYSE">ERF</a>) rose 13.7% to $18.67.</li>
<li>Indivior PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indv#NASDAQ">INDV</a>) gained 13.3% to $19.83 following fourth-quarter results.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) rose 12.2% to $13.88.</li>
<li>Agile Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agrx#NASDAQ">AGRX</a>) gained 11.1% to $1.10. Agile Therapeutics was granted extension by Nasdaq Hearings Panel to regain compliance until March 25, 2024. The company sees FY23 revenue of $20 million to $21 million. Agile Therapeutics announces exercise of warrants for $4.8 million gross proceeds.</li>
<li>Synopsys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snps#NASDAQ">SNPS</a>) gained 10.7% to $601.93 after the company reported better-than-expected first-quarter adjusted EPS results and issued strong guidance.</li>
<li>Q2 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtwo#NASDAQ">QTWO</a>) rose 9.5% to $45.82 following strong results.</li>
<li>Eastside Distilling, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/east#NASDAQ">EAST</a>) shares rose 7.6% to $1.0340.</li>
<li>DigitalOcean Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docn#NYSE">DOCN</a>) gained 6.8% to $38.29 following upbeat results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Draganfly Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dpro#NASDAQ">DPRO</a>) shares fell 50.3% to $0.1790 after the company announced pricing of $3.6 million underwritten public offering.</li>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) fell 46.6% to $0.2024 after the company announced a $1.2 million registered direct offering of 6 million shares at $0.20 per share purchase price.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) shares fell 29.5% to $0.1839 after surging 29% on Wednesday. Synaptogenix received a Notice of Allowance for its U.S. Patent application 17/665,033 titled &quot;Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases.&quot;</li>
<li>Rivian Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) fell 26.8% to $11.25 after the company reported a wider-than-expected loss for its fourth quarter and announced plans to reduce its salaried workforce by around 10% to help further improve costs. The company said it sees production of 57,000 vehicles in 2024.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 23.2% to $1.0750.</li>
<li>Goosehead Insurance, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gshd#NASDAQ">GSHD</a>) dipped 21.2% to $68.78 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Bel Fuse Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/belfa#NASDAQ">BELFA</a>) fell 20.1% to $59.16 after the company reported weak fourth-quarter financial results.</li>
<li>Lucid Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lcid#NASDAQ">LCID</a>) shares fell 19.1% to $2.9912 after the company reported mixed fourth-quarter financial results and issued guidance.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) dipped 18.6% to $9.52 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>ATN International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atni#NASDAQ">ATNI</a>) declined 18.1% to $29.20 after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Pulmonx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lung#NASDAQ">LUNG</a>) fell 17.6% to $11.94 after the company reported fourth-quarter financial results.</li>
<li>MGP Ingredients, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgpi#NASDAQ">MGPI</a>) declined 14.3% to $78.75 after the company reported fourth-quarter financial results.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares fell 13.1% to $0.5995 after declining around 7% on Wednesday.</li>
<li>Standard Motor Products, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smp#NYSE">SMP</a>) dipped 12.7% to $35.01 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Teekay Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tk#NYSE">TK</a>) gained 12.4% to $7.21 after the company reported a year-over-year decrease in Q4 financial results.</li>
<li>TrueCar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/true#NASDAQ">TRUE</a>) dipped 11% to $3.4450 following weak sales.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktos#NASDAQ">KTOS</a>) fell 8% to $18.57. Kratos Defense &amp; Security Solutions announced a proposed public offering of $300 million of common stock.</li>
<li>Rogers Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rog#NYSE">ROG</a>) fell 6.8% to $108.29 following weak quarterly results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37262506/booking-holdings-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earni"> Booking Holdings Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call </a>

Penny Stocks

ACVA

AGRX

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

ATNI

BBLG

BELFA

BZFD

DOCN

DPRO

EAST

ETSY

EZFL

GBNH

GSHD

INDV

LCID

LNTH

LRHC

LUNG

MATV

MGPI

MNPR

MNTS

NOVA

NVAX

NVDA

OCUL

QTWO

RELY

RILY

RIVN

ROOT

RXRX

SNPS

SNPX

TRUE

VERO

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Rogers shares are trading lower after the company reported worse-than-expected Q4 financial results and issued Q1 guidance below estimates.

New facility will support growing EV/HEV and renewable energy demand in North America
Rogers Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) announced today that it has signed a lease on a factory in Monterrey, Mexico for advanced busbar manufacturing and engineering services. The first phase of the new site is slated for completion in late 2024 and continues Rogers' manufacturing footprint strategy of supporting customers in the regions where they operate.
Rogers' advanced ROLINX&#xAE; busbars provide effective and efficient power distribution in a variety of applications in the electric and hybrid-electric vehicle (EV/HEV), renewable energy, mass transit and industrial markets. Customers choose ROLINX&#xAE; busbars based on Rogers' proven quality and reliability, electrical and mechanical expertise, co-engineering support and flexible lead times.
"We are excited to expand our presence in North America to better support our global customers and the growing EV/HEV and renewable energy markets in this region. Our new factory in Monterrey will enable us to better support our customers with deeper technical collaboration, and local prototyping and supply capabilities that reduce lead times and improve service levels," said Jeff Tsao, Advanced Electronic Solutions (AES) Senior Vice President and General Manager.
This latest investment continues Rogers' support of growth opportunities across its markets with ongoing initiatives to drive capacity throughput improvements at existing facilities and make targeted investments in new capacity.

Global

Rogers Corporation Announces New Factory In Monterrey, Mexico; New Facility Will Support Growing EV/HEV And Renewable Energy Demand In North America

Rogers Sees Q1 2024 Adj. EPS $0.45-$0.65 Vs $1.03 Est.; Revenue $205M-$215M Vs $229.40M Est.

Rogers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROG#NYSE">ROG</a>) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Rogers missed estimated earnings by 40.0%, reporting an EPS of $0.6 versus an estimate of $1.0.
Revenue was down $19.10 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.11 which was followed by a 0.45% increase in the share price the next day.
Here's a look at Rogers's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.13</td>
<td>1.02</td>
<td>0.72</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.24</td>
<td>1.07</td>
<td>0.87</td>
<td>1.04</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>235.00M</td>
<td>241.05M</td>
<td>235.00M</td>
<td>235.40M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>229.15M</td>
<td>230.82M</td>
<td>243.85M</td>
<td>223.70M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Rogers <a href="https://www.benzinga.com/quote/ROG/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Rogers Q4 Earnings

MKS Instruments announces new CFO

Rogers Corporation Eyes Growth In EV And Renewable Energy Markets Despite Profit Challenges

Rogers Q3 2024 Earnings Preview

Here are the major earnings after the close today

Rogers Non-GAAP EPS of $0.98 beats by $0.13, revenue of $210.3M misses by $9.8M

An update from Rogers ( ($ROG) ) is now available. Rogers Corporation reported mixed financial results for Q3 2024, with earnings surpassing expect...

Rogers Corporation Q3 2024 Earnings Beat Expectations

Reports Q3 revenue $210.3M, two estimates $220.1M. "Third-quarter results were mixed with earnings that exceeded our guidance expectations and sale...

Rogers Corporation reports Q3 adjusted EPS 98c, two estimates 85c

Sees Q4 revenue $185M-$200M, two estimates $211.75M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia...

Rogers Corporation sees Q4 adjusted EPS 30c-60c, two estimates 83c

Rogers Corporation 2024 Q3 - Results - Earnings Call Presentation

Rogers Corporation (ROG) Q3 2024 Earnings Call Transcript

BYON

CINF

COUR

DECK

ENSG

GLPI

MGRC

SPSC

SSNC

TROX

TXRH

VALE

VRSN

ZYXI

Press Releases

Rogers Corporation Releases Its 2024 Environmental, Social and Governance Report

Rogers Corporation Schedules Second Quarter 2024 Earnings Call for July 25

Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo

Rogers Corporation Reports Second Quarter 2024 Results

Rogers Corporation Announces Departure of Chief Financial Officer

Ram Mayampurath to Join MKS Instruments as Chief Financial Officer

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

Comments

Rogers

Vendite allo scoperto

Rogers (NYSE:ROG) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO